+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers



BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers



Japanese Journal of Cancer Research 91(5): 519-526



To understand the biological role of BRCA1 in sporadic breast cancers, the relationship between DNA methylation of the BRCA1 promoter region and BRCA1 expression was studied using molecular biological and immunohistochemical methods. Furthermore, BRCA1 expression was compared with the expression of various cell cycle regulatory proteins and the morphological nuclear grade of cancer cells. Of 32 sporadic breast cancers investigated in this study, 10 (31%) revealed DNA methylation of the BRCA1 promoter region. The expression of BRCA1 was observed in the nuclei of cancer cells and 18 (56%) of 32 cancers were positive for BRCA1 immunoreactivity. Breast cancers with BRCA1 methylation lacked BRCA1 expression, except for only three cancers, and there was a significant inverse relationship between BRCA1 methylation and its expression in sporadic breast cancers (P = 0.043). Compared with the expression of various cell cycle regulatory proteins, breast cancers with BRCA1 methylation showed decreased expression of estrogen receptor (P = 0. 016) and p27 (P = 0.018) and increased expression of p21 (P = 0.011). Furthermore, breast cancers without BRCA1 expression or with BRCA1 methylation had a tendency to contain nuclei with higher grade. These findings indicate that BRCA1 methylation might greatly influence its expression and BRCA1 expression might play an important role in cell cycle regulation and influence the grade of malignancy of sporadic breast cancers.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010225539

Download citation: RISBibTeXText

PMID: 10835497

DOI: 10.1111/j.1349-7006.2000.tb00976.x


Related references

Methylation of the BRCA1 promoter in sporadic breast cancer related to BRCA1 copy number and pathologic features. Proceedings of the American Association for Cancer Research Annual Meeting 44: 987-988, 2003

Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 17(14): 1807-1812,. 8, 1998

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Research 65(23): 10692-9, 2005

BRCA1 inactivation in sporadic breast cancer is associated with aberrant cytosine methylation and alterations in chromatin structure of the BRCA1 CpG island promoter. Proceedings of the American Association for Cancer Research Annual Meeting 40: 443, 1999

Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Research and Treatment 111(1): 113-120, 2008

Methylation of the BRCA1 promoter is associated with decreased BRCA1 expression in clinical breast cancer specimens. Proceedings of the American Association for Cancer Research Annual Meeting (41): 658, 2000

BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients. Breast Cancer Research and Treatment 135(1): 135-143, 2012

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics. Oncogene 18(11): 1957-1965, 1999

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Research and Treatment 91(2): 179-186, 2005

Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer. Oncology Letters 9(4): 1807-1813, 2015

Down-regulation of BRCA1 in human sporadic breast cancer; Analysis of DNA methylation patterns of the putative promoter region. Oncogene 17(24): 3169-3176, 1998

BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Research and Treatment 129(1): 69-77, 2011

Association of BRCA1 promoter methylation with rs11655505 c2265Cgt;T variants and decreased gene expression in sporadic breast cancer. 2013

Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer. Clinical and Translational Oncology 15(7): 555-562, 2013

Correlation of BRCA1 protein expression with BRCA1 gene mutation in sporadic ovarian cancers. Laboratory Investigation 81(1): 147A, 2001